FGEN

FibroGen Stock Price

43.49
-1.02 (-2.29%)
Upgrade to Real-Time
Afterhours (Closed)
43.49
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.02 -2.29% 43.49 20:00:00
Close Price Low Price High Price Open Price Previous Close
43.49 42.88 44.20 43.94 44.51
Bid Price Ask Price Spread News
42.25 47.75 5.50 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10,710 939,639 $ 43.31 $ 40,697,643 798,312 22.65 - 53.97
Last Trade Time Type Quantity Stock Price Currency
16:00:35 20 $ 43.49 USD

FibroGen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.93B 90.36M 78.92M $ 256.58M $ - -0.96 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 131.39k 5.00%

more financials information »

FibroGen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week42.7445.9842.6044.20802,1450.751.75%
1 Month42.2853.9740.72543.07895,5061.212.86%
3 Months40.4053.9739.6943.05638,3893.097.65%
6 Months25.4853.9724.5439.23683,80818.0170.68%
1 Year40.2753.9722.6539.41701,3413.228.0%
3 Years53.8068.5522.6545.56621,649-10.31-19.16%
5 Years29.8868.5514.3839.26564,19213.6145.55%

FibroGen Description

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.


Your Recent History
NASDAQ
FGEN
FibroGen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.